First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
…, B Rha, SKK Sakthivel, SE Smith-Jeffcoat, E Soda… - The Lancet, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. …
respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. …
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States
…, D Russell, S Scott, V Shetty, SE Smith-Jeffcoat… - PloS one, 2020 - journals.plos.org
Coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has …
respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China and has …
[HTML][HTML] Multistate outbreak of SARS-CoV-2 B. 1.1. 529 (Omicron) variant infections among persons in a social network attending a convention—New York City …
SE Smith-Jeffcoat - MMWR. Morbidity and Mortality Weekly Report, 2022 - cdc.gov
… , Christopher Merkel, Monmouth County Health Department; Dawn Saady, Virginia
Department of Health; Elizabeth Traub, Los Angeles County Department of Public Health; …
Department of Health; Elizabeth Traub, Los Angeles County Department of Public Health; …
Symptoms, Viral Loads, and Rebound Among Coronavirus Disease 2019 (COVID-19) Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity …
SE Smith-Jeffcoat, JE Biddle, HK Talbot… - Clinical Infectious …, 2023 - academic.oup.com
Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus disease
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score–Matched Untreated …
SE Smith-Jeffcoat, JE Biddle, HK Talbot… - Clinical Infectious …, 2024 - academic.oup.com
Background Nirmatrelvir/ritonavir (N/R) reduces severe outcomes from coronavirus disease
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
2019 (COVID-19); however, rebound after treatment has been reported. We compared …
[HTML][HTML] Effects of patient characteristics on diagnostic performance of self-collected samples for SARS-CoV-2 testing
SE Smith-Jeffcoat, M Koh, A Hoffman… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We evaluated the performance of self-collected anterior nasal swab (ANS) and saliva samples
compared with healthcare worker–collected nasopharyngeal swab specimens used to …
compared with healthcare worker–collected nasopharyngeal swab specimens used to …
[HTML][HTML] SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance—Respiratory Virus Transmission Network, November 2022–May 2023
SE Smith-Jeffcoat - MMWR. Morbidity and Mortality Weekly Report, 2024 - cdc.gov
As population immunity to SARS-CoV-2 evolves and new variants emerge, the role and
accuracy of antigen tests remain active questions. To describe recent test performance, the …
accuracy of antigen tests remain active questions. To describe recent test performance, the …
Changes in Transmission and Symptoms of SARS-CoV-2 in United States Households, April 2020–September 2022
…, C Ogokeh, PP Salvatore, C Reed, SE Smith-Jeffcoat… - medRxiv, 2023 - medrxiv.org
Background The natural history of SARS-CoV-2 infection and transmission dynamics may
have changed as SARS-CoV-2 has evolved and population immunity has shifted. Methods …
have changed as SARS-CoV-2 has evolved and population immunity has shifted. Methods …
Specimen self-collection for SARS-CoV-2 testing: Patient performance and preferences—Atlanta, Georgia, August-October 2020
K O'Laughlin, CC Espinosa, SE Smith-Jeffcoat, M Koh… - Plos one, 2022 - journals.plos.org
Self-collected specimens can expand access to SARS-CoV-2 testing. At a large inner-city
hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before …
hospital 1,082 participants self-collected saliva and anterior nasal swab (ANS) samples before …
Risk-Factors for Exposure Associated With SARS-CoV-2 Detection After Recent Known or Potential COVID-19 Exposures Among Patients Seeking Medical Care at a …
SE Smith-Jeffcoat, S Sleweon, M Koh… - Frontiers in public …, 2022 - frontiersin.org
We aimed to describe frequency of COVID-19 exposure risk factors among patients
presenting for medical care at an urban, public hospital serving mostly uninsured/Medicare/Medicaid …
presenting for medical care at an urban, public hospital serving mostly uninsured/Medicare/Medicaid …
